P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 201–300 of 1,000
Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
Weyerhäuser, P., Kantelhardt, S. R., & Kim, E. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00335 · Cited by 79
González‐Menéndez, P., Hevia, D., Mayo, J. C., & Sainz, R. M. (2017) · International Journal of Cancer · doi:10.1002/ijc.31165 · Cited by 86
Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria
Qian, M., Liu, Z., Peng, L., Tang, X., Meng, F., Ao, Y., Zhou, M., Wang, M., Cao, X., Qin, B., et al. (2018) · eLife · doi:10.7554/elife.34836 · Cited by 77
“As p53 is critical in glycolysis (Kruiswijk et al., 2015; Schwartzenberg-Bar-Yoseph et al., 2004), we further analyzed metabolomics of Atm-/- and control MEFs in p53 null background.”
TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network
Krell, J., Stebbing, J., Carissimi, C., Dabrowska, A. F., de Giorgio, A., Frampton, A. E., Harding, V., Fulci, V., Macino, G., Colombo, T., et al. (2015) · Genome Research · doi:10.1101/gr.191759.115 · Cited by 82
“A number of chemotherapeutic agents with anti-cancer activity act as DNA damaging agents, including doxorubicin (DOX), which induces double-strand DNA breaks (DSBs) that activate TP53-mediated cell signalling pathways such as apoptosis, senescence and cell cycle arrest (Krell et al. 2013; Kruiswijk et al. 2015).”
BackgroundPinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
“, its expression is high during cell division but rapidly declines during cell cycle arrest [67].”
BackgroundInfluentialCellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers
Kumar, R., Coronel, L., Somalanka, B., Raju, A., Aning, O. A., An, Ö., Ho, Y. S., Chen, S., Mak, S. Y., Hor, P. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05805-1 · Cited by 81
Li, K., Li, D., Zhao, L., Chang, Y., Zhang, Y., Cui, Y., & Zhang, Z. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.04.010 · Cited by 74
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Gonzalez-Rellan, M. J., Fondevila, M. F., Fernandez, U., Rodríguez, A., Varela‐Rey, M., Veyrat‐Durebex, C., Seoane, S., Bernardo‐Seisdedos, G., Lopitz‐Otsoa, F., Fernández‐Ramos, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25390-0 · Cited by 81
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“Modulators of the p53 pathway have gained attention as potential senolytic agents owing to the role of p53 in controlling senescence and apoptosis, particularly through its regulation of BCL-2 family proteins 118,119 .”
Blanden, A. R., Yu, X., Blayney, A. J., Demas, C., Ha, J.-H., Liu, Y., Withers, T., Carpizo, D. R., & Loh, S. N. (2020) · eLife · doi:10.7554/elife.61487 · Cited by 78
“Introduction The transcription factor p53 regulates a host of cellular responses to damage and distress (Kruiswijk et al., 2015).”
BackgroundThe Transcriptional Landscape of p53 Signalling Pathway
Tanikawa, C., Zhang, Y., Yamamoto, R., Tsuda, Y., Tanaka, M., Funauchi, Y., Mori, J., Imoto, S., Yamaguchi, R., Nakamura, Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.017 · Cited by 77
“Additionally, p53 regulates various biological processes, such as metabolic pathways, aging, development, the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). reprogramming, and reproduction (Hu et al., 2007; Kang et al., 2009; Kruiswijk et al., 2015).”
BackgroundInfluentialTumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2
Xu, R., García-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 81
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
“In addition, mutations in the p53 gene and interactions between the p53 protein and other proteins can cause inactivation of its normal function 54,55 .”
Backgroundp53: A double-edged sword in tumor ferroptosis
Ji, H., Wang, W., Li, X., Han, X., Zhang, X., Wang, J., Liu, C., Huang, L., & Gao, W. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106013 · Cited by 78
Cold Physical Plasma Modulates p53 and Mitogen-Activated Protein Kinase Signaling in Keratinocytes
Schmidt, A., Bekeschus, S., Jarick, K. J., Hasse, S., von Woedtke, T., & Wende, K. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7017363 · Cited by 73
“The cellular tumor antigen p53 is basically a transcription factor with a major role in DNA damage sensing and control, hypoxia, or nutrient fluctuation [23].”
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 78
Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury
Tang, W., Panja, S., Jogdeo, C. M., Tang, S., Ding, L., Yu, A., Foster, K. W., Dsouza, D. L., Chhonker, Y. S., Jensen‐Smith, H. C., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121562 · Cited by 72
Jiang, H., Ma, N., Shang, Y., Zhou, W., Chen, T., Guan, D., Li, J., Wang, J., Zhang, E., Feng, Y., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.156 · Cited by 72
Molecular signature of anastasis for reversal of apoptosis
Tang, H. M., Talbot, C. C., Fung, M. C., & Tang, H. L. (2017) · F1000Research · doi:10.12688/f1000research.10568.2 · Cited by 81
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69
“In addition, the role of “everyday” p53 has been gaining attention to highlight its role beyond causing tumor suppression, as p53 has been shown to regulate key homeostatic processes, such as metabolism, stem cell development and differentiation, and aging [13,14].”
Backgroundp53 pathway is involved in cell competition during mouse embryogenesis
Zhang, G., Xie, Y., Zhou, Y., Xiang, C., Chen, L., Zhang, C., Hou, X., Chen, J., Zong, H., & Liu, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617414114 · Cited by 69
“p53 is known to play a significant role in influencing the metabolic and redox profiles of cells (34), which might be associated with the cells’ competitive status.”
BackgroundP53 in skin cancer: From a master player to a privileged target for prevention and therapy
Loureiro, J. B., Abrantes, A. M., Oliveira, P. A., & Saraiva, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188438 · Cited by 81
TP53 drives invasion through expression of its Δ133p53β variant
Gadéa, G., Arsic, N., Fernandes, K., Diot, A., Joruiz, S. M., Abdallah, S., Meuray, V., Vinot, S., Anguille, C., Reményi, J., et al. (2016) · eLife · doi:10.7554/elife.14734 · Cited by 74
“…of TP53 do not totally abrogate its tumor suppressor activity and can confer additional biological activities to TP53 gene, it is very difficult to choose the most efficient cancer treatment based on TP53 mutation status ( Kruiswijk et al., 2015 ; Lang et al., 2004 ; Li et al., 2012 ; Meek, 2015 ).”
STIM-Orai Channels and Reactive Oxygen Species in the Tumor Microenvironment
Frisch, J., Angenendt, A., Hoth, M., Prates Roma, L., & Lis, A. (2019) · Cancers · doi:10.3390/cancers11040457 · Cited by 68
“This downstream effect can be lost upon the mutation and absence of p53, finally leading to ROS accumulation and a pro-tumorigenic phenotype [116,169].”
BackgroundRole of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 77
“About 30% of mutations occur in six amino acid residues, which are most frequently mutated in human cancers, including Arg175, Gly245, Arg248, Arg249, Arg273, and Arg282 [78].”
BackgroundCell death pathologies: targeting death pathways and the immune system for cancer therapy
Pentimalli, F., Grelli, S., Daniele, N. D., Melino, G., & Amelio, I. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0052-x · Cited by 75
Repression of P53 Function by SIRT5-Mediated Desuccinylation at Lysine 120
Liu, X., Rong, F., Tang, J., Zhu, C., Chen, X., Jia, S., Wang, Z., Sun, X., Deng, H., Zha, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-021-00886-w · Cited by 72
Ferroptosis and Its Potential Role in the Nervous System Diseases
Zhou, Y., Lin, W., Rao, T., Zheng, J., Zhang, T., Zhang, M., & Lin, Z. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351799 · Cited by 73
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
Barili, V., Fisicaro, P., Montanini, B., Acerbi, G., Filippi, A., Forleo, G., Romualdi, C., Ferracin, M., Guerrieri, F., Pedrazzi, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14137-7 · Cited by 75
Zhou, Y., Niu, W., Luo, Y., Li, H., Xie, Y., Wang, H., Liu, Y., Fan, S., Li, Z., Xiong, W., et al. (2019) · Cancer Science · doi:10.1111/cas.13928 · Cited by 66
p53-dependent elimination of aneuploid mitotic offspring by entosis
Liang, J., Niu, Z., Zhang, B., Yu, X., Zheng, Y., Wang, C., Ren, H., Wang, M., Ruan, B., Qin, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00645-3 · Cited by 71
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Zhang, M., & Tang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114474 · Cited by 74
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Determinants of nutrient limitation in cancer
Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 72
“Among its many functions, p53 allows cells to adapt to nutrient deprivation (Kruiswijk et al. 2015).”
BackgroundCycling back to folate metabolism in cancer
Lee, Y., Vousden, K. H., & Hennequart, M. (2024) · Nature Cancer · doi:10.1038/s43018-024-00739-8 · Cited by 75
“…and DNA methylation 44 . p53 is a tumor-suppressor protein that is lost or mutated in most cancers 82 . p53 responds to oncogenic stress and, depending on the context, either helps cells to survive and adapt to mild or transient stress or eliminates cells exposed to persistent or severe stress 83 .”
Self-citationUzilov, A. V., Taik, P., Cheesman, K. C., Javanmard, P., Ying, K., Roehnelt, A., Wang, H., Fink, M. Y., Lau, C. Y., Moe, A. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa853 · Cited by 72
Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
Homayoonfal, M., Asemi, Z., & Yousefi, B. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00320-0 · Cited by 69
“P53 is a signaling pathway well recognized as a “genome guardian” owing to its predominant roles in managing cell processes such as apoptosis, cell proliferation, cell survival, and cell death [75].”
BackgroundImmunosenescence in atherosclerosis: A role for chronic viral infections
Talepoor, A. G., & Doroudchi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945016 · Cited by 71
Wu, Y., Zhang, C., Xiong, J., Cai, D.-Q., Wang, C.-Z., Wang, Y., Liu, Y., Wang, Y., Li, Y., Wu, J. H., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00874-4 · Cited by 73
“Consistent with the previous reports showing that AMPK is not involved in promoting p-Ser46, 41,42 we observed similar levels of p-Ser46 in AMPK α -DKO (double knock-out of AMPK α 1 and AMPK α 2 ) HEK293 cells, either in low glucose or in the presence of 2-DG (Fig.”
ResultLi, X., Cheng, K. K. Y., Liu, Z., Yang, J., Wang, B., Jiang, X. X., Zhou, Y., Hallenborg, P., Hoo, R. L. C., Lam, K. S. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11740 · Cited by 74
Roles of the BAP1 Tumor Suppressor in Cell Metabolism
Han, A., Purwin, T. J., & Aplin, A. E. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3430 · Cited by 70
“For example, TP53 mutations contribute to increased glycolysis and redox homeostasis (10).”
BackgroundEnhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells
Zhang, H., Zhong, X., Zhang, X., Shang, D., ZHOU, Y., & Zhang, C. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2912 · Cited by 63
“In the present study, the pathways involved in naringenin and ABT-737-induced cell apoptosis, including the p53 and Akt pathways that are important in cell apoptosis and survival (24,25), were investigated (Fig.”
Backgroundp53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine
Krstić, J., Galhuber, M., Schulz, T. J., Schupp, M., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030921 · Cited by 70
“For instance, p53 acts to limit glycolysis in breast cancer cells, while it induces glycolytic enzymes in muscle cells [24].”
BackgroundWatanabe, H., Ishibashi, K., Mano, H., Kitamoto, S., Sato, N., Hoshiba, K., Kato, M., Matsuzawa, F., Takeuchi, Y., Shirai, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.081 · Cited by 60
Haploinsufficient tumor suppressor genes.
Inoue, K., & Fry, E. A. (2017) · PubMed · Cited by 85
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism
Xu, Y., Qiu, M., Shen, M., Dong, S., Ye, G., Shi, X., & Sun, M. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.017 · Cited by 69
Understanding the Cause and Consequence of Tumor Heterogeneity
Khatib, S., Pomyen, Y., Dang, H., & Wang, X. W. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.010 · Cited by 60
Metabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 66
p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation
Artigas, N., Gámez, B., Cubillos‐Rojas, M., Sánchez‐de‐Diego, C., Valer, J. A., Pons, G., Rosa, J. L., & Ventura, F. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.113 · Cited by 68
“As a canonical tumour suppressor, p53 is supposed to inhibit proliferation but also promote differentiation.(36) However, the inhibitory role of p53 in osteogenic differentiation, in a cellautonomous manner, is well established by mouse genetics and cell-based approaches.”
BackgroundInfluentialA Protective Role for Triacylglycerols during Apoptosis
Li, N., Sancak, Y., Frasor, J. M., & Atilla‐Gokcumen, G. E. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00975 · Cited by 70
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
Liu, J., Li, J., Li, P., Wang, Y., Liang, Z., Jiang, Y., Li, J., Feng, C., Wang, R., Chen, H., et al. (2017) · Scientific Reports · doi:10.1038/srep42125 · Cited by 61
Warburg effect in Gynecologic cancers
Kobayashi, Y., Banno, K., Kunitomi, H., Takahashi, T., Takeda, T., Nakamura, K., Tsuji, K., Tominaga, E., & Aoki, D. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13867 · Cited by 66
Parkinson's disease‐associated protein Parkin: an unusual player in cancer
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Cancer Communications · doi:10.1186/s40880-018-0314-z · Cited by 37
Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy
Liu, Y. U., Leslie, P. L., & Zhang, Y. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.005 · Cited by 67
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Wang, M., & Attardi, L. D. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-025840 · Cited by 66
Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
Maganti, H. B., Jrade, H., Cafariello, C., Rothberg, J. L. M., Porter, C. J., Yockell‐Lelièvre, J., Battaion, H. L., Khan, S. T., Howard, J. P., Li, Y., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0841 · Cited by 60
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Ogretmen, B., Krupenko, S. A., & Krupenko, N. I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716902 · Cited by 59
“The tumor suppressor p53 is a transcription factor commonly activated upon certain types of cellular stress such as DNA damage, nutrient starvation, ribosomal stress or oncogenic signaling (1-4).”
BackgroundInfluentialMetabolic regulation by p53 prevents R-loop-associated genomic instability
Panatta, E., Butera, A., Mammarella, E., Pitolli, C., Mauriello, A., Leist, M., Knight, R. A., Melino, G., & Amelio, I. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111568 · Cited by 63
“Although implicated in cancermetabolism and genomic integrity via multiple mechanisms, the molecular basis underlying p53-dependent maintenance of genome integrity appears to be fundamentally complex (Aubrey et al., 2018; Brady et al., 2011; Kruiswijk et al., 2015; Valente et al., 2013).”
BackgroundInsulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
Werner, H., Sarfstein, R., LeRoith, D., & Bruchim, I. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00159 · Cited by 63
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease
Blandino, G., Valenti, F., Sacconi, A., & Agostino, S. D. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.011 · Cited by 62
p53‐mediated adaptation to serine starvation is retained by a common tumour‐derived mutant
Humpton, T. J., Hock, A. K., Maddocks, O. D. K., & Vousden, K. H. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0191-6 · Cited by 58
“These different and opposing functions of p53 have been rationalised in a model where p53 responds to transient metabolic stress by supporting cell survival and repair, while more severe damage or persistent stress promotes p53 responses that eliminate the affected cell [5].”
Self-citationFunction of reactive oxygen species in myeloid-derived suppressor cells
Huang, J., Zhao, Y., Zhao, K., Yin, K., & Wang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226443 · Cited by 70
Chessari, G., Hardcastle, I. R., Ahn, J. S., Anil, B., Anscombe, E., Bawn, R. H., Bevan, L., Blackburn, T. J., Buck, I. M., Cano, C., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02188 · Cited by 59
Cross-Talk between p53 and Wnt Signaling in Cancer
Xiao, Q., Werner, J., Venkatachalam, N., Boonekamp, K. E., Ebert, M. P. A., & Zhan, T. (2022) · Biomolecules · doi:10.3390/biom12030453 · Cited by 63
“As a response to these stimuli, p53 can trigger apoptosis, cell cycle arrest and senescence through the transcription activation of key regulators (Figure 1A) [6,13].”
BackgroundHaploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development
Ren, N. S. X., Ji, M. H., Tokar, E. J., Busch, E. L., Xu, X., Lewis, D., Li, X., Jin, A., Zhang, Y., Wu, W. K. K., et al. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.047 · Cited by 60
“It has been increasingly recognized that a major impact of genetic mutations in cancer cells is to reprogram their metabolic pathways to maximize use of nutrients under various nutritional and stress conditions [2, 6, 7].”
Wang, Z., Yang, K., Zheng, Q., Zhang, C., Tang, H., Babicheva, A., Jiang, Q., Li, M., Chen, Y., Carr, S. G., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00538.2017 · Cited by 62
“The tumor-suppressive function of p53 has been extensively investigated in malignant conditions, leading to the deduction of its crucial roles in cell-cycle arrest, apoptosis, and senescence (32, 48, 67).”
BackgroundInsights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts
Hyun, D. (2020) · Cancers · doi:10.3390/cancers12071822 · Cited by 61
“This change can be induced by activating oncogenes such as Ras, and inhibiting tumor suppressor genes such as p53 [4,5].”
BackgroundPrion-like p53 Amyloids in Cancer
Navalkar, A., Ghosh, S., Pandey, S., Paul, A., Datta, D., & Maji, S. K. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00796 · Cited by 60
Martin, P., Yin, J., Seng, V., Casey, O., Corey, E., Morrissey, C., Simpson, R. M., & Kelly, K. (2016) · Oncogene · doi:10.1038/onc.2016.223 · Cited by 52
Bright Polymer Dots Tracking Stem Cell Engraftment and Migration to Injured Mouse Liver
Chen, D., Li, Q., Meng, Z., Guo, L., Tang, Y., Liu, Z., Yin, S., Qin, W., Yuan, Z., Zhang, X., et al. (2017) · Theranostics · doi:10.7150/thno.18614 · Cited by 57
“The p21 acts as a potent cyclin-dependent kinase inhibitor that regulates cell cycle [62].”
BackgroundTriclosan-induced liver injury in zebrafish (Danio rerio) via regulating MAPK/p53 signaling pathway
Liu, M., Ai, W., Sun, L., Fang, F., Wang, X., Chen, S., & Wang, H. (2019) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2019.04.016 · Cited by 56
Birts, C. N., Banerjee, A., Darley, M., Dunlop, C. R., Nelson, S., Nijjar, S. K., Parker, R., West, J. J., Tavassoli, A., Rose-Zerilli, M. J. J., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aau9529 · Cited by 61
Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
“P53 pathway modulators— P53 controls senescence and apoptosis in part via regulation of BCL-2 (68, 69).”
BackgroundLiu, S., Kim, T.-H., Franklin, D. A., & Zhang, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.086 · Cited by 60
“To further investigate the mechanisms behind the specific metabolic alterations observed after HFD feeding in Mdm2C305F mice, we performed real-time quantitative polymerase chain reaction (qRT-PCR) to evaluate additional p53 target genes with particular interest in genes associated with metabolism in adipose tissue (B…”
MethodMungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54
“…is stabilized and recruits core transcriptional machinery proteins to its target promoters, enabling transactivation of these genes, with cellular outcomes including cell-cycle arrest and apoptosis (Kruiswijk et al., 2015; Mandinova and Lee, 2011; Vousden and Prives, 2009; Zilfou and Lowe, 2009).”
Mutant p53 in cell-cell interactions
Pilley, S., Rodriguez, T. A., & Vousden, K. H. (2021) · Genes & Development · doi:10.1101/gad.347542.120 · Cited by 53
“The induction of a p53 response can help cells deal with stress by supporting adaptation and survival or induce a permanent withdrawal of proliferative capacity through the induction of differentiation, senescence, or cell death (Kruiswijk et al. 2015).”
BackgroundSelf-citationLipid and glucose metabolism in senescence
Liu, B., Meng, Q., Gao, X., Sun, H., Xu, Z., Wang, Y., & Zhou, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1157352 · Cited by 60
Cheng, X., Ali, M. S. S. H., Moran, M., Viana, M. P., Schlichte, S. L., Zimmerman, M. C., Khalimonchuk, O., Feinberg, M. W., & Sun, X. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101863 · Cited by 57
Yin Yang 1 sustains biosynthetic demands during brain development in a stage-specific manner
Zurkirchen, L., Varum, S., Giger, S., Klug, A., Häusel, J., Bossart, R., Zemke, M., Cantù, C., Atak, Z. K., Zamboni, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09823-5 · Cited by 54
Cell Death Response to DNA Damage.
Wang, J. Y. J. (2019) · Europe PMC (PubMed Central) · Cited by 86
Regulation of gene expression in human cancers by TRIM24
Appikonda, S., Thakkar, K. N., & Barton, M. C. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.05.001 · Cited by 60
Ren, J., Ding, L., Xu, Q., Shi, G., Li, X., Li, X., Ji, J., Zhang, D., Wang, Y., Wang, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00913-2 · Cited by 54
Xie, J., Li, Y., Jiang, K., Hu, K., Zhang, S., Dong, X., Dai, X., Liu, L., Zhang, T., Yang, K., et al. (2018) · Theranostics · doi:10.7150/thno.21963 · Cited by 52
“The samples were then incubated with HA-p53-WT or HA-p53-S315A in 50 μL of kinase buffer (Cell Signaling Technology) containing 10 μM ATP for 30 min at 30 °C.”
BackgroundInfluentialDeciphering the PTM codes of the tumor suppressor p53
Wen, J., & Wang, D. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab047 · Cited by 59
“…have shown that wild-type p53 is a bona fide homeostasis maintainer and tumor suppressor that is extensively involved in cell cycle arrest, apoptosis, DNA repair, cellular senescence, metabolic processes, etc. (Kruiswijk et al., 2015; Kastenhuber and Lowe, 2017; Li et al., 2019; Liu and Gu, 2021).”
BackgroundExploiting the p53 Pathway for Therapy
Cheok, C. F., & Lane, D. P. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026310 · Cited by 52
“…oxidation provides a source of energy and ATP generation through OXPHOS (oxidative phosphorylation) in p53-proficient cells to maintain viability (Kruiswijk et al. 2015). p53deficient cells, however, are more vulnerable to energy fluctuations as a result of being less able to use other…”
Backgroundp53 regulates lipid metabolism in cancer
Chen, L., & Wang, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.188 · Cited by 54
Protective role of p53 in acetaminophen hepatotoxicity
Huo, Y., Yin, S., Yan, M., Win, S., Aung Than, T., Aghajan, M., Hu, H., & Kaplowitz, N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.028 · Cited by 49
“However, an increasing body of evidence supports a pro-survival function of p53 activation in certain conditions (5-7).”
Regulation of p53 stability as a therapeutic strategy for cancer
Xu, Z., Wu, W., Yan, H., Hu, Y., He, Q., & Luo, P. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114407 · Cited by 54
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 58
“TP53 is also involved in cancer metabolic regulation [90,91].”
BackgroundThe TP53 tumor suppressor gene: From molecular biology to clinical investigations
Baliakas, P., & Soussi, T. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20106 · Cited by 50
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65–67].”
Maitisha, G., Aimaiti, M., An, Z., & Li, X. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06722-1 · Cited by 54
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 63
“P53 Regulates Metabolism to Suppress Tumorigenesis P53 also plays an important role in metabolic homeostasis [347–349].”
BackgroundCell biology-metabolic crosstalk in glioma
Colquhoun, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.022 · Cited by 51
Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity
Tarangelo, A., Rodencal, J., Kim, J. T., Magtanong, L., Long, J. Z., & Dixon, S. J. (2022) · Life Science Alliance · doi:10.26508/lsa.202101157 · Cited by 56
“In addition to its well-established role in apoptosis, the p53 pathway regulates ferroptosis sensitivity (Jiang et al, 2015; Kruiswijk et al, 2015; Xie et al, 2017; Tarangelo et al, 2018; Chu et al, 2019; Venkatesh et al, 2020a).”
Zhu, M., He, Q., Wang, Y., Duan, L., Rong, K., Wu, Y., Ding, Y., Mi, Y., Ge, X., Yang, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1238841 · Cited by 50
Zhen, Z., Ren, S.-H., Ji, H., Ma, J., Ding, X., Feng, F., Chen, S.-L., Zou, P., Ren, J., & Jia, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.023 · Cited by 51
p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer
Chang, H. W., Kim, M. R., Lee, H. J., Lee, H. M., Kim, G. C., Lee, Y. S., Nam, H. Y., Lee, M., Jang, H. J., Lee, K. E., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0697-6 · Cited by 50
Mueller, F. B., Yang, H., Lubetzky, M., Verma, A., Lee, J. R., Dadhania, D. M., Xiang, J., Salvatore, S., Seshan, S. V., Sharma, V. K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128014 · Cited by 50
Luo, Q., Pan, W., Zhou, S., Wang, G., Yi, H., Zhang, L., Yan, X., Yuan, L., Liu, Z., Wang, J., et al. (2020) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504020x15825405463920 · Cited by 49
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.